MedPath

Clinical study on Anti-Hair Fall Herbal Shampoo

Phase 2
Completed
Registration Number
CTRI/2022/12/048268
Lead Sponsor
Believe Pte. Ltd.,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1. Willing to give informed consent.

2. Healthy Indian male/female volunteer aged between 18-55 years (both inclusive)

3. Must be able to adhere to the study visit schedule and other protocol requirements.

4. Willing to complete the questionnaires.

5. Subjects experiencing mild to moderate hair loss.

6. Willing to avoid usage of his/her own hair oils, shampoo and other hair products for at least one week before commencement and during this study.

Exclusion Criteria

1. Pregnancy or breast feeding.

2. Inability to provide voluntary consent.

3. Patients with pre-existing severe systemic disease necessitating long-term medication.

4. Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation.

5. History of cancer, including solid tumours, hematologic malignancies and carcinoma in situ

6. On any medication or supplement for hair loss including finasteride, any other 5-alpha- reeducate inhibitors, minoxidil, steroids or hormonal products during the 3 months prior to study commencement.

7. On any medication or supplement against dandruff including ketoconazole, Selenium sulfide, Salicylic acid, Pyrithione zinc etc during the 3 months prior to study commencement.

8. History of hypersensitivity reactions.

9. Recently undergone hair transplant surgery.

10. Use of any anti-psychotic drugs for one week prior to Baseline.

11. Use of any investigational medication within 4 weeks prior to start of study drug.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢% Change in the average decrease in hair fall (tested through 60 second hair comb test, hair pull test) from baseline to last visitTimepoint: Day 0 to Day 45
Secondary Outcome Measures
NameTimeMethod
To evaluate consumer acceptance as well as their response toward the product through a feedback questionnaire.Timepoint: Day 0 to Day 45
© Copyright 2025. All Rights Reserved by MedPath